ADTX (aditxt.com) Return on Sales by Gross Profit

Corporate emblem and logo of Aditxt (ADTX)

Gross sales margins demonstrate the stability of Aditxt against a backdrop of a neutral geopolitical climate in the US, where the value is fixed at 0.00. However, the company faces risks due to potential disruptions in biocomponent supplies and restrictions on international data exchange. Business revenues are based on the sale of precision medicine and immunity monitoring systems for specialized diagnostic centers.

Aditxt (ADTX) - Return on Gross Profit from 07/04/2022 to 07/11/2026

Financial and market metric breakdowns for Aditxt, Inc. (ADTX)

Fundamental valuation:Aditxt, Inc.
Flagship merchandise of aditxt.com

For Aditxt, which specializes in high-precision immunity monitoring via the Pears platform, the gross margin reflects the monetization efficiency of its unique organ rejection prevention technologies. This metric is calculated as the share of revenue minus direct production costs, allowing the company to filter out random profit spikes. The average gross margin trend confirms the business's ability to scale its innovative product without a proportional increase in cost of goods sold, ensuring long-term sustainability.

Key competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Return on Gross Profit DNTH (Dianthus Pharma)|Return on Sales by Gross Profit Pharvaris N.V.|AbCellera Biologics Inc - Return on Gross Profit|Tourmaline Bio (TRML) - Gross Profit Margin|PGEN - Gross Profitability|Gross Profit Rate PHAR (Pharming Group NV)|NKTR: Gross Margin|Upstream Bio Corp - Gross Profit Rate|Gross Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Return on Sales by Gross Profit|Gross Margin GOSS|Return on Gross Profit KalVista Pharmaceuticals, Inc. KALV|Gross Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Gross Profit Margin|SVRA - Gross Profitability|Rigel Pharmaceuticals - Gross Profit Ratio|AnaptysBio Corp (ANAB) - Gross Profitability|ATXS - Return on Sales by Gross Profit|Gross Profitability enGene Holdings Inc.|RAPT: Gross Profit Rate|Gross Margin JBIO|Return on Gross Profit aclaristx.com ACRS|Gross Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Gross Profit Margin|Cabaletta Bio, Inc - Gross Margin|Gross Profit Margin Ventyx Biosciences|THTX (theratech.com) - Return on Gross Profit|Return on Gross Profit Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Gross Margin|Gross Profit Margin Agenus Inc. AGEN|Return on Gross Profit CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Gross Profit Rate|Gross Profitability atyrpharma.com ATYR|Gross Margin Adagene Corp ADAG|IMA - Gross Profitability|Gross Profit Rate STTK (Shattuck Labs)|EQ: Gross Margin|Connect Biopharma (CNTB) - Gross Margin|Gross Profitability Immunic|Gross Margin atarabio.com|Gross Margin IFRX|Gross Margin X4 Pharma (XFOR)|Gross Margin ACET (adicetbio.com)|Gross Margin Celularity Inc. CELU|INMB - Gross Profitability|Gross Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Return on Gross Profit|Return on Gross Profit SAB Biotherapeutics Inc.|Return on Gross Profit AKTX|Return on Gross Profit enlivex.com (ENLV)|Gross Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Gross Sales Margin|Gross Margin EDSA (Edesa Biotech Corp)|Return on Sales by Gross Profit iBio (IBIO)|CARM - Gross Profitability|XTL Biopharmaceuticals (XTLB) - Return on Gross Profit|BOLT: Gross Margin|Return on Gross Profit HCW Biologics Inc.|Gross Profitability Aptevo|Gross Return on Sales AIM (AIM ImmunoTech, Inc.)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability